Volker Wagner
Chief Medical Officer OranoMed
Seminars
Wednesday 12th November 2025
Expanding TRP Therapy into Neuroendocrine Tumours: Targeting SSTR2 with 212Pb
4:00 pm
- Discussing Orano Med’s unique approach to TAT with 212Pb
- Presenting the latest updates on 212Pb-DOTAMTATE
- Exploring Orano Med’s portfolio of 212Pb-based TATs
